Amgen
AMGN
1,518 hedge funds and large institutions have $99.2B invested in Amgen in 2016 Q3 according to their latest regulatory filings, with 112 funds opening new positions, 630 increasing their positions, 564 reducing their positions, and 52 closing their positions.
115% more first-time investments, than exits
New positions opened: 112 | Existing positions closed: 52
13% more funds holding in top 10
Funds holding in top 10: 86 → 97 (+11)
12% more repeat investments, than reductions
Existing positions increased: 630 | Existing positions reduced: 564
9% more capital invested
Capital invested by funds: $91.2B → $99.2B (+$8B)
3% more funds holding
Funds holding: 1,474 → 1,518 (+44)
0.09% less ownership
Funds ownership: 80.06% → 79.97% (-0.09%)
18% less call options, than puts
Call options by funds: $1.03B | Put options by funds: $1.26B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$720M |
| 2 |
State Street
Boston,
Massachusetts
|
+$591M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$367M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$148M |
| 5 |
Renaissance Technologies
New York
|
+$122M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$670M |
| 2 |
GE
General Electric
Evendale,
Ohio
|
-$476M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$426M |
| 4 |
Primecap Management
Pasadena,
California
|
-$351M |
| 5 |
D.E. Shaw & Co
New York
|
-$217M |
AMGN Hedge Fund Activity: Q3 2016 in Review
1,518 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Amgen (AMGN) for Q3 2016, worth a combined $99.2B — up 8.8% from $91.2B a quarter earlier.
Buyers outnumbered sellers: 112 funds opened new AMGN positions and 52 closed out — a net gain of 60 holders — while 630 added to existing stakes and 564 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $720M. The largest seller was Capital Research Global Investors, cutting an estimated $670M.
- 1,518 institutional investors held Amgen (AMGN) as of Q3 2016, up from 1,474 in Q2 2016.
- Funds reported $99.2B of Amgen stock for Q3 2016, up 8.8% quarter-over-quarter.
- 112 funds opened new Amgen positions in Q3 2016 and 52 closed out, a net change of +60 holders.
- The largest Amgen buyer in Q3 2016 was Fidelity Investments, an estimated $720M added.
- The largest Amgen seller in Q3 2016 was Capital Research Global Investors, an estimated $670M sold.
Based on aggregated 13F filings for Q3 2016.